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Abstract We previously reported that the injection of
nitrogen-containing bisphosphonate (NBP) induced the site
of erythropoiesis to shift from the bone marrow (BM) to the
spleen. Our previous study established a severely anemic
mouse model that was treated with a combination of NBP
with phenylhydrazine (PHZ), which induced newly discov-
ered hematopoietic organs in the omentum. No reports have
shown that new hematopoietic organs form under any condi-
tion. We characterized the structures and factors related to the
formation of these new organs. Splenectomized mice were
treated with NBP to inhibit erythropoiesis in the BM and then
injected with PHZ to induce hemolytic anemia. The mice
showed severe anemia and wine-colored structures appeared
in the omentum. Some hematopoietic cells, including mega-
karyocytes, and well-developed sinuses were observed in
these structures. Numerous TER119-positive erythroblasts
were located with cells positive for PCNA, a cell proliferation
marker. C-kit-positive cells were detected and mRNAs related
to hematopoiesis were expressed in these structures.
Moreover, TER119-positive erythroblasts emerged and
formed clusters and hematopoiesis-related factors were detect-
ed in the omentum of mice treated with NBP and PHZ. The
levels of G-CSF in the serum and hematopoietic progenitor
cells (HPCs) in the peripheral blood were increased upon
treatment with both NBP and PHZ. These results suggest that
the induced hematopoietic structures act as the sites of eryth-
ropoiesis and that NBP-induced G-CSF production causes
HPC mobilization, homing and colonization in the omentum
because they constitutively express some factors, including
SDF-1; thus, the newly discovered hematopoietic structure
in this study might be formed.
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Introduction
In adult mammals, hematopoiesis occurs in the bone marrow
(BM) under normal conditions. BM possesses a specializedmi-
croenvironment called the ‘niche’ that maintains hematopoietic
stem cells (HSCs) (McGrath and Palis 2008; Palis 2009). The
stem cell niche, which is composed of cellular compartments
such as osteoblasts, endothelial cells and adipocytes, has been
reported to support hematopoiesis, hematopoietic cell homing,
the establishment of resistance for self-renewal and the differen-
tiation of hematopoietic lineage cells (Johns and Christopher
2012; Rankin et al. 2012). The niches in the BM are classified
into two main types: an osteoblastic niche and a vascular niche.
Osteoblastsproduceseveralcytokines,suchasG-CSF,GM-CSF
and SDF-1. The conditional ablation of osteoblasts results in a
reduction in the number of hematopoietic cells, includingHSCs
(Visnjic et al. 2004; JohnsandChristopher2012). In contrast, the
factors leading to the establishment of HSCswithin the vascular
niche are notwell understood. It has been shown that the recruit-
ment of progenitors, including megakaryocytes, to the vascular
niche involves signaling through SDF-1 and FGF-4 (Avecilla
et al. 2004). The vascular niche seems to be associated with
extramedullary hematopoiesis in the liver and spleen through
the expression of SDF-1, which plays an essential role in the
homing of HSCs and hematopoietic progenitor cells (HPCs) to
BM (Inra et al. 2015;Mendt and Cardier 2015).
In adult mice, erythropoiesis occurs in the BM and spleen
throughout life, even under normal conditions. The spleen is
the main site of extramedullary hematopoiesis in response to
acute anemia to maintain hematopoietic homeostasis. The liv-
er has also been reported to promote extramedullary erythro-
poiesis in response to anemia in splenectomized mice (Lenox
et al. 2009). In certain pathological conditions, extramedullary
erythropoiesis is also detected in several organs, including the
liver, lungs and hemal nodes (Halder et al. 2003; Bowling
et al. 2008; Lenox et al. 2009). It has been reported that several
factors induce extramedullary erythropoiesis, bone marrow
failure, accelerated erythropoiesis, such as hypoxia and a
marked stimulation of granulopoiesis (O’Malley 2007).
Hypoxia caused by severe anemia is a primary stimulus for
myelostimulatory extramedullary hematopoiesis, whereby in-
creased erythropoietin (EPO) production in the kidney stimu-
lates the proliferation and maturation of erythroid precursors
(Lacombe and Mayeux 1998; Paliege et al. 2010). In humans,
therapeutic G-CSF and GM-CSF treatments infrequently
cause extramedullary hematopoiesis in the spleen and in other
embryonic hematopoietic sites (Lacombe and Mayeux 1998).
Recently, G-CSFwas found tomobilizeHSCs and HPCs from
the BM to peripheral tissues, thus expanding the
extramedullary pool of stem cells available for extramedullary
hematopoiesis (Greenbaum and Link 2011; Li et al. 2012).
Bisphosphonates (BPs) are potent inhibitors of osteoclast-
mediated bone resorption and are used as therapeutic agents
against bone resorptive disorders, such as osteoporosis and
metastatic bone diseases (Body 2003; Cremers et al. 2003).
Nitrogen-containing bisphosphonates (NBPs) have strong
anti-bone resorptive effects that are much more powerful than
non-nitrogen-containing bisphosphonates (non-NBPs) and
they exhibit inflammatory side effects (Endo et al. 1999;
Nakamura et al. 1999; Yamaguchi et al. 2010). Our previous
study established extramedullary erythropoiesis in livers with-
out anemia and changes in serum EPO concentrations follow-
ing the injection of NBP in splenectomized mice (Otsuka et al.
2011). We also reported the establishment of a severely anemic
mouse model following treatment with both NBP and
phenylhydrazine (PHZ) to induce hemolytic anemia and iden-
tified a new hematopoietic structure in the omentum (Otsuka
et al. 2016). This is the first report of the newly induced hema-
topoietic structure in mice, even in anemic conditions.
Here, we identified the morphological features and forma-
tion mechanism of the newly induced structure in this study.




Sixty female BALB/c mice (6 weeks old) were obtained from
Sankyo Laboratories (Tokyo, Japan) and housed under specific
pathogen-free conditions. The mice were anesthetized with an
intraperitoneal injectionof sodiumpentobarbital (50mg/kg) and
splenectomieswere performed, as described in a previous report
(Otsuka et al. 2011). The mice were divided into 2 groups, a
splenectomized control group (20 mice) and a splenectomized
and NBP and PHZ treatment group (40 mice). Seven days after
splenectomy, NBP (40 μmol/kg) or sterile saline (control) was
intraperitoneally injected into the splenectomized mice. Two
days after NBP injection, the mice were treated with PHZ
(50 mg/kg) or saline (control) and then euthanized 3 days after
PHZ treatment. The experimental schedule is shown in Fig. 1a.
TheNBP used in this studywas 4-amino-1-hydroxybutylidene-
1, 1-bisphosphonate (AHBuBP), which was prepared as previ-
ously described (Endo et al. 1999; Nakamura et al. 1999).
All experimental protocols used in this study were
reviewed and approved by the Animal Care Committee of
Showa University (Permit Number: 15018, 16015).
Blood analyses
Peripheral blood samples were collected and centrifuged at
10,000g for 5 min to determine hematocrit values and the sera
were separated by centrifugation at 1,000g for 15 min. To mea-
sure the serum EPO and G-CSF levels, we used an EPOMouse
ELISA Kit and a G-CSF Mouse ELISA Kit (R & D Systems,
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Fig. 1 Experimental schedule and analysis of the peripheral blood. a A
schematic of the experimental schedule. Blood samples were collected
daily (arrowhead) and tissue samples were obtained 3 days after PHZ
injection. b The hematocrit values at 3 days after PHZ (5 days after NBP)
injection. A significant reduction was observed in the animals treated with
both NBP and PHZ compared with the controls. c The serum EPO
concentration at 3 days after PHZ (5 days after NBP) injection. A
significant increase was observed in the animals treated with both NBP
and PHZ. d The time-dependent change in the hematocrit values (dashed
line) and serum EPO concentrations (solid line) in the animals treated
with both NBP and PHZ. A significant reduction in the hematocrit values
and an increase in the EPO concentrations were observed 1 day after PHZ
injection. e, f Blood smears from control animals (e) and animals treated
with both NBP and PHZ (at 3 days after PHZ; f) were stained with May-
Grünwald Giemsa stain. Nucleated erythroid cells were easily detected in
the mice treated with both NBP and PHZ (NBP + PHZ; arrows). g Flow
cytometry analysis of CD71-positive erythroid lineage cells in the periph-
eral blood at 3 days after the PHZ (5 days after NBP) injection, which
were gated as TER119-positive cells. The majority of cells in the controls
were single-positive TER119 cells, whereas the number of TER119- and
CD71-double-positive cells was significantly increased following treat-
ment with both NBP and PHZ (NBP + PHZ). Error bars standard error of
the mean (SEM). Scale bars (e, f) 10 μm. *P < 0.05 (vs. control or 0 day)
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Minneapolis, MN, USA), according to the manufacturer’s pro-
tocols and whole blood was prepared as a blood smear and
stained using the May-Grünwald Giemsa staining technique.
Antibodies and other materials
Themonoclonalantibodiesusedinthisstudyarelistedbelow.The
purified anti-mouse TER-119, Gr-1, B220, CD3 and PCNA and
PE-conjugated anti-mouse TER-119 antibodies were purchased
from BD Pharmingen (San Diego, CA, USA). APC-conjugated
CD71, PE-conjugated anti-Sca1 and APC-conjugated anti-c-kit
antibodies were purchased from Biolegend (San Diego, CA,
USA). Biotinylated anti-c-kit antibody was purchased from
Abcam (Cambridge, UK). Normal rabbit IgG, biotinylated goat
anti-rat IgG, biotinylated goat anti-mouse IgG, biotinylated goat
anti-hamster IgG, Texas Red-conjugated goat anti-Rat IgG anti-
bodies and an avidin-biotin complex kit (ABCElite standard kit)
were purchased from Vector Laboratories (Burlingame, CA,
USA). The anti-mouse F4/80 antibody was obtained from AbD
Serotec (Kidington, UK). The Lineage Cell Depletion kit was
purchased fromMiltenyi Biotec (BergischGladbach,Germany).
Flow cytometry
To analyze the erythroid lineage cells in the peripheral blood, the
cells were isolated from the peripheral blood, as previously de-
scribed (Otsuka et al. 2016),washedusingFACSsolution (1mM
EDTA, 0.2%BSA and 0.1%NaN3 in PBS) and incubated with
PE-conjugated anti-TER-119 and APC-conjugated anti-CD71
antibodies (1:200)or rat IgG(isotypecontrol) in1%BSAinPBS.
To detect the hematopoietic precursor cells in the BM and
peripheral blood, the cells from each tissue were obtained,
depleted of erythrocytes, washed with FACS solution and in-
cubated with a Lineage Cell Depletion kit according to the
manufacturer’s protocol. These labeled cells were separated
using AutoMACS Pro (Miltenyi Biotec) and the separated
lineage-negative cells were stained with PE-conjugated anti-
Sca1 and APC-conjugated anti-c-kit antibodies (dilute 1:200)
or rat IgG (isotype control) in 1 % BSA in PBS.
After washing, the cells were resuspended in FACS solu-
tion and analyzed using a BDAccuri C6 Flow Cytometer (BD
Bioscience, Rockville, MD, USA). The data were collected
for 10,000 events and subsequently analyzed using the C6
Sampler software (BD Bioscience).
Tissue preparation
The tissue samples were fixed in 4 % paraformaldehyde pre-
pared in PBS, washed in 20 % sucrose-PBS, embedded in
O.C.T. compound (Sakura Finetek Japan, Tokyo, Japan) and
quickly frozen in a mixture of acetone and dry ice. Frozen
sections (8 μm thick) were cut, placed on SILANE-coated
glass slides and air-dried.
Histology and immunohistochemistry
Some sections were stained with hematoxylin-eosin (HE).
The remaining sections were rinsed in PBS and the sections
for PCNA, a cell proliferation marker, were incubated in cit-
rate buffer (pH 6.0) for 10 min at 121 °C for antigen retrieval.
The sections were fixed in 1 % H2O2 in PBS for 30 min to
quench endogenous peroxidases. After several PBS washes,
the sections were incubated in 5 % normal goat serum in PBS.
These sections were then incubated with anti-TER119, anti-
Gr-1, anti-CD3, anti-B220, anti-F4/80 and anti-PCNA anti-
bodies (1:100). After several rinses with PBS, the sections
were incubated with biotinylated goat anti-rat, anti-mouse or
anti-hamster antibodies, followed by a solution containing the
avidin-biotin-horseradish peroxidase complex (ABC Elite
standard kit). After washing, the sections were incubated with
a mixture from the DAB detection kit (KPL, Gaithersburg,
MD, USA). Hematoxylin was used as the counterstain.
Immunofluorescence staining
The sections of newly discovered structures were rinsed in
PBS and incubated with 5 % normal goat serum in PBS and
then incubated with anti-c-kit monoclonal antibody (1:100).
After several rinses with PBS, the sections were incubated
with Texas Red-conjugated goat anti-rat IgG antibody. After
the sections were washed with PBS, the sections were incu-
bated with DAPI, washed with PBS and observed using a BZ-
X710 fluorescence microscope (Keyence, Osaka, Japan).
Transmission electron microscopy (TEM)
and immunocytochemistry
The newly discovered hematopoietic structures were prepared
for TEM. They were fixed in 2 % paraformaldehyde and
2.5 % glutaraldehyde in 0.1 M sodium cacodylate buffer,
post-fixed in 2 % osmium tetroxide, dehydrated through a
graded series of ethanol solutions, passed through propylene
oxide and embedded in EPON 812 (TAAB, Aldermaston,
UK).
For the immunocytochemical detection of TER-119-
positive cells, the frozen sections were used in an immunohis-
tochemical technique and re-fixed in 2.5 % glutaraldehyde
before incubation with the DAB solution. After incubation
with DAB, the sections were post-fixed in 2 % osmium te-
troxide, dehydrated through a graded series of ethanol solu-
tions and embedded in EPON 812.
Ultra-thin sections (80 nm thick) were cut and stained with
uranyl acetate and lead citrate and observed under a Hitachi H-
7600 transmission electron microscope (Hitachi, Tokyo,
Japan).
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RT-PCR
Total RNA from the newly discovered hematopoietic struc-
tures and mesenteric lymph nodes of the NBP- and PHZ-
treated mice and the omentum of the control and NBP- and
PHZ-treated mice were isolated using an RNeasy Mini kit
(QIAGEN, Hilden, Germany). The total RNA was reverse
transcribed into cDNA using a PrimeScript RT reagent kit
(Takara, Shiga, Japan). PCR was performed using a Veriti
Thermal Cycler (Applied Biosystems, Foster City, CA,
USA) with ExTaq (Takara) and the primer sequences and
annealing temperatures are listed in Table 1.
Colony forming assay
Colony-forming (CF) assays were performed according to the
manufacturer’s protocol. The cells isolated from the BM and
peripheral blood of the control mice and animals treated with
NBP and PHZ (3 days after PHZ injection) were depleted of
erythrocytes and the cells were plated in Methocult GF
M3434 (1.3 % methylcellulose, 15 % fetal bovine serum,
2 % bovine serum albumin, 50 ng/ml SCF, 10 ng/ml IL-3,
10 ng/ml IL-6 and 5 IU/ml EPO) (STEMCELL
Technologies, Vancouver, BC, Canada) and cultured at
37 °C for 10 days. Burst-forming unit-erythroid (BFU-E)
and the other colonies (CFU-M, CFU-G, or CFU-GM) were
counted after 10 days of culture.
Statistical analysis
For the quantitative data analysis, t tests were used to deter-
mine the differences between paired samples. A p value of
<0.05 was considered statistically significant.
Results
Blood analyses
We collected peripheral blood to evaluate the hematocrit
values, measure the serum EPO concentrations and observe
the erythrocytes in blood smears. In splenectomized mice
treated with both NBP and PHZ (3 days after PHZ injection),
a significant reduction in the hematocrit value was observed
compared with the control mice (Fig. 1b). The concentration
of EPO in the serum was also markedly increased at 3 days
after PHZ injection (Fig. 1c). The hematocrit values in animals
treated with both NBP and PHZ were significantly reduced in
a time-dependent manner following NBP injection. The con-
centration of EPO in serum taken 1–3 days after PHZ treat-
ment was also significantly increased compared with the se-
rum taken 0 days after NBP injection (Fig. 1d).
The blood smears showed only normal enucleated erythro-
cytes in the control mice (Fig. 1e). In contrast, numerous nu-
cleated erythrocytes and reticulocytes were observed in the
Table 1 Sequence of used primer
in this study Name Sequence Anealing temperature (°C)
Product size (bp)
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peripheral blood of mice treated with both NBP and PHZ
(Fig. 1f). Flow cytometry was performed to detect the propor-
tion of CD71-positive cells in the TER119-positive peripheral
blood cells. Most of the TER119-positive cells in the controls
were CD71-negative erythrocytes, whereas the numbers of
TER119- and CD71-double-positive cells were markedly in-
creased in the animals treated with both NBP and PHZ
(Fig. 1g).
These results indicate that splenectomized mice treated
with NBP and PHZ become severely anemic with significant-
ly increasing EPO levels to enhance erythropoiesis, similar to
our previous report (Otsuka et al. 2016).
Morphological study of the newly discovered structures
Wine-colored structures appeared in the omentum or pancreas
of the animals treated with both NBP and PHZ (Fig. 2a). The
size of these structures was 0.1–1.0 mm and they had fibrous
capsules in the omentum (Fig. 2b, c), although the small size
of the structures was not clearly distinct from the surrounding
tissues (Fig. 2e, f). The histological study showed that there
were lymphoid follicle-like cell clusters and well-developed
sinusoids, similar to the spleen (Fig. 2b, c) and that some
hematopoietic cells, including megakaryocytes, populated
these structures (Fig. 2d). To detect whether erythropoiesis
occurred in the induced structures, an immunohistochemical
analysis was performed to detect the TER119-positive cells.
Numerous TER119-positive, nucleated cells were detected in
these structures (Fig. 2g, h).
These results indicate the possibility that newly discovered
structures in a severe anemic mouse model play a role as the
site of extramedullary hematopoiesis.
Immunohistochemical detection and TEM observation
of hematopoietic cells in the newly discovered structures
To identify the hematopoietic cells in the newly discovered
hematopoietic structures, we performed immunohistochemis-
try for the following lineage markers: Gr-1, B220, CD3 and
F4/80. Nucleated cells formed clusters in these structures and
these cells were TER119-negative and were surrounded by a
sinus (Fig. 3a, b). These clusters were formed by B220-
positive B lymphocytes (Fig. 3c). However, the B lympho-
cytes did not form lymphoid follicles. There were very few
CD3-positive T-lymphocytes in these structures and they did
not form a T lymphocyte region, as observed in the lymph
node or spleen (Fig. 3d). Gr1-positive granulocytes existed in
the periphery (Fig. 3e) and F4/80-positive macrophages were
diffusely located in the region occupied by the TER119-
positive erythroblasts in these structures (Fig. 3f). The lym-
phoid follicle-like clusters were filled with TER119-positive
cells (Fig. 3g, h). Most of these cells were PCNA-positive
proliferating cells (Fig. 3h, i).
The ultrastructural study indicated the presence of numer-
ous hematopoietic cells, including megakaryocytes and eryth-
roblasts, whose cytoplasm was filled with free ribosomes and
Fig. 2 Morphological study of the newly induced structures in the
abdominal cavity. a Macroscopic observation of the abdominal cavity.
Wine-colored structures were observed in the omentum in
splenectomized mice treated with both NBP and PHZ (arrow). b The
histological analysis included HE staining of the newly identified struc-
tures. Some lymphoid follicle-like structures were observed. cHigh mag-
nification of (b). A fibrous capsule surrounded the newly identified struc-
ture (arrows). d High magnification of (c). Numerous hematopoietic
cells, including megakaryocytes (arrow), were observed in these struc-
tures. e HE staining of the newly identified structures (arrow) in the
pancreas. fHigh magnification of (e). The fibrous capsule of the structure
was not observed. g, h Immunohistochemical detection of the TER119-
positive cells. Most of the cells in this structure were TER119-positive
erythroblasts in the newly induced structures. Scale bars (b) 200 μm, (c,
e, f, h) 100 μm, (d, g) 25 μm. pc pancreas
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Fig. 3 Histological study of the hematopoietic cells in the newly
discovered hematopoietic structure. a–c The serial sections with HE
staining (a) or immunohistochemistry for TER119 (b) and B220 (c).
B220-positive cells formed a cluster (arrow) surrounded by a sinus and
TER119-positive erythroblasts. There were no lymphoid follicles, such as
those observed in lymph nodes. d–f Immunohistochemistry for CD3 (d),
Gr-1 (e) and F4/80 (f). CD3-positive T-lymphocyte (arrow), Gr1-positive
granulocytes (arrow) and F4/80-positive macrophages (arrow) were
diffusely observed in these structures. g HE staining of the newly identi-
fied structures. h Immunohistochemical detection of the TER119-positive
cells in serial sections of (g). Some lymphoid follicle-like structures were
f o rmed by TER119 - po s i t i v e e r y t h r o b l a s t s (a r row ) . i
Immunohistochemistry for PCNA in serial sections of (h). Most
TER119-positive cells were located with PCNA-positive cells (arrow).
Scale bars (a–c) 50 μm, (d–f) 20 μm, (g–i) 100 μm
Fig. 4 TEM observation of the
newly discovered structure. a
Some hematopoietic cells,
including a megakaryocyte, were
observed in this structure. b Some
erythroblasts (arrow), which were
filled with free ribosomes and thin
cell organelles, were observed in
the structures. c TER119-positive
erythroblasts (arrow) and nucle-
ated erythrocytes were present in
the structures. d Cell division was
observed in the structures. e A
rough endoplasmic reticulum-rich
fibroblast actively produced col-
lagen fibers (arrow). Scale bars
(a) 4 μm, (b) 2.5 μm, (c–e) 2 μm
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thin cell organelles (Fig. 4a, b). Immunocytochemistry
showed the presence of TER119-positive erythroblasts
(Fig. 4c). Some of the cells were undergoing cell division
(Fig. 4d) and some fibroblasts, which had abundant rough
endoplasmic reticulum (rER), produced the collagen fibers
(Fig. 4e).
These results indicate that active erythropoiesis occurs in
these structures. The main function of the newly discovered
structure is erythropoiesis and is not an acquired immunore-
action, such as that in lymphoid organs, because B cells did
not form the lymphoid follicle and T cells did not form a
specific region.
Immunofluorescence staining of hematopoietic progenitor
cells and mRNA expression of hematopoiesis-related
factors in the newly discovered hematopoietic structures
We performed immunofluorescence staining for c-kit to iden-
tify the hematopoietic progenitor cells (HPCs) in the newly
discovered structures. Some c-kit-positive cells were detected
in these structures (Fig. 5a).Moreover, we performed RT-PCR
of hematopoiesis-related cytokines to identify the microenvi-
ronment in the induced structures compared with the mesen-
teric lymph node. mRNAs associated with hematopoiesis,
such as SCF (Scf), IL-3 (Il3), M-CSF (Csf1), G-CSF (Csf2),
and GM-CSF (Csf3) and the homing factor SDF-1 (Cxcl12)
were detected in the induced structures (Fig. 5b, b’). The
erythropoiesis-related factors EPO receptor (Epor) were also
detected in the newly discovered hematopoietic structures but
not in the MLN (Fig. 5b, b’). The expression of β-actin (Actb)
was used as an internal control. These results suggest that
HPCs exist in the newly discovered hematopoietic structure
and that the microenvironment in the structure is suitable for
differentiation of HPCs and erythropoiesis.
Histological analysis of the omentum
The newly discovered hematopoietic structures usually
emerged in the omentum. Therefore, we performed morpho-
logical observations in the omentum to identify the progenitor
structure for hematopoiesis. We observed cell clusters called
the omental milky spot in the omentum, which was composed
of lymphocytes and macrophages around blood vessels and
the lymphoid cells that had infiltrated between the adipocytes.
A histological analysis of the HE staining indicated that there
was no change in the omental milky spot following treatment
with both NBP and PHZ compared with the control
(Fig. 6a, b). Based on immunohistochemistry, the TER119-
positive erythrocytes were only observed in the blood vessels
in the control (Fig. 6c), whereas the TER119- and CD71-pos-
itive, nucleated cells formed clusters in the omentum of mice
treated with both NBP and PHZ (Fig. 6d, e). The TER119-
positive, nucleated erythroblasts and erythrocytes formed an
agglomeration in the capillary lumen (Fig. 6f). These results
show that the omental milky spots are not likely affected by
hypoxia but that the mobilized erythroid progenitor cells col-
onize in the omentum following treatment with both NBP and
PHZ.
mRNA expression of hematopoiesis-related factors
in the omentum
We performed RT-PCR to identify the omentum in the control
animals and animals treated with both NBP and PHZ to iden-
tify the expression of cytokines related to hematopoiesis. SCF
(Scf), MCSF (Csf1) and SDF-1 (Cxcl12) were expressed in the
omentum of both groups but GATA1 (Gata1) and EPO recep-
tor (Epor), which are related to erythropoiesis, were only de-
tected in the animals treated with both NBP and PHZ
(Fig. 6g). These results suggest that erythropoiesis is induced
in the omentum following treatment with both NBP and PHZ.
The omentum seems to possess a suitable microenvironment
for hematopoiesis because it expresses several factors, includ-
ing SDF-1, even in normal conditions (Fig. 6g). Increased
levels of these cytokines might support the observed mobili-
zation of HPCs homing, colonization and differentiation in
peripheral tissues in this study.
Fig. 5 Immunofluorescence staining and RT-PCR analysis of the newly
discovered hematopoietic structures. a Immunofluorescence staining of
c-kit in the induced structure. Some c-kit-positive cells were observed in
the structure. b, b’ Comparison of the mesenteric lymph node (MLN) and
the newly discovered hematopoietic structure (induced structure). Some
mRNAs of cytokines (Scf, Il3, Csf13 and Cxcl12) related to hematopoi-
esis and Epor were expressed in the newly discovered hematopoietic
structure. Scale bar (a) 20 μm
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CF assays and quantitative analyses of HPCs in BM
and peripheral blood
To evaluate the hematopoietic ability of mononuclear cells in
the BM and peripheral blood, we performed a CF assay. In the
BM, no significant change was detected between the control
mice and mice treated with both NBP and PHZ (Fig. 7a).
However, a significant increase in the number of colonies
was induced in the cells from the peripheral blood of mice
treated with both NBP and PHZ compared with the control
mice (Fig. 7c). We also analyzed the number of lineage-
negative and c-kit-positive HPCs (LK cells) in the BM and
peripheral blood after NBP injection to detect the mobilization
of the HPCs from the BM to the peripheral tissues. The pop-
ulation of LK cells was significantly decreased in the BM at
1–2 days after NBP injection, whereas it was markedly in-
creased in the peripheral blood during the same period follow-
ing treatment (Fig. 7b, d). Moreover, these LK cells entirely
recovered to their normal levels in the BM at 3 days after NBP
injection (Fig. 7b). However, the number of cells was still
significantly increased in the peripheral blood after PHZ in-
jection (Fig. 7d).
Measurement of G-CSF in the serum
We next measured the serum G-SCF concentrations because
G-CSF is the key cytokine associated with the mobilization of
HSCs and the transport of HPCs from the BM to peripheral
tissues. One day after NBP injection, the G-CSF levels in-
creased precipitously and remained at a high concentration
for up to 3 days after NBP treatment, which was well corre-
lated with the decrease in the number of LK cells in the BM
(Figs. 7b, e; S1). NBP has been reported to enhance
granulopoiesis and inflammation (Nakamura et al. 1999),
which might be mediated by G-CSF stimulation. Our results
suggested that G-CSF production was stimulated by NBP
treatment, which then provoked the mobilization of HPCs
from the BM to the peripheral tissue.
Fig. 6 Histological study and RT-PCR analysis of the omental milky
spot. a, b In the HE staining, no changes were observed in the NBP-
and PHZ-treated mice (b) compared with the control mice (a). c, d
Immunohistochemistry for TER119. TER119-positive cells were only
present in the capillaries in the controls (c) but TER119-positive, nucle-
ated cells formed a cluster in the animals treated with both NBP and PHZ
(d, arrow). e Immunohistochemistry for CD71. CD71-positive erythro-
blast clusters were observed in the omentum of mice treated with both
NBP and PHZ (arrow). f Immunocytochemistry for TER119. TER119-
positive erythroblasts and nucleated erythrocytes accumulated in the si-
nusoidal lumen in the omentum of mice treated with NBP and PHZ. The
arrowhead indicates the endothelium. g RT-PCR analysis of the omenta
of the controls and animals treated with both NBP and PHZ. Some
hematopoiesis-related factors were detected following treatment with
NBP and PHZ. In addition, some mRNAs (Scf, Csf1 and Cxcl12) were
also detected in the control animals. Scale bars (a–e) 25 μm, (f) 4 μm
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Discussion
In adult vertebrates, the main hematopoietic organ normally
becomes localized in the BM. However, extramedullary
hematopoiesis occurs under several conditions (Halder et al.
2003; Bowling et al. 2008; Lenox et al. 2009). Many reports
have shown that extramedullary erythropoiesis in the liver was
induced in splenectomized mice under acute anemic condi-
tions (Halder et al. 2003; Lenox et al. 2009). Our previous
study also showed that a severely anemic mouse model was
established by treating the animals with both NBP and PHZ
and that numerous erythroblasts formed clusters in the liver
(Otsuka et al. 2016). We unexpectedly observed an undiscov-
ered, wine-colored structure in the abdominal cavity in this
model (Otsuka et al. 2016). In the present study, we showed
the morphological features, functions and the mechanism of
the formation of this newly discovered structure. These newly
discovered structures always emerged in the omentum or pan-
creas and were filled with numerous erythroblasts. Well-
developed sinuses were also detected. These newly discov-
ered structures are very similar to the hemal node and/or he-
molymph node (Turner 1969; Casteleyn et al. 2008; Zidan and
Pabst 2010). Hemal nodes or hemolymph nodes are lymphoid
organs. The hemal node has some lymphoid follicles, similar
to lymph nodes but the sinusoidal systems are more extensive,
similar to the spleen and contain blood instead of lymph, pro-
ducing a red macroscopic appearance (Zhang et al. 2013).
These are observed in a wide range of animals, including
man. However, these organs have never been identified in
the mouse (Van den Broeck et al. 2006). These structures
provide the site of hematopoiesis under certain pathological
conditions, such as acute anemia (Cerutti and Guerrero 2008)
but their main roles are to destroy erythrocytes and mediate an
immune response by trapping reticulo-endothelial compo-
nents and processing antigenic material and erythrocytes
(Schultz et al. 1973). The newly discovered hematopoietic
structures in this study were the site of extramedullary eryth-
ropoiesis but they did not play a function as lymphoid organs.
In addition, the newly discovered hematopoietic structures did
not form lymphoid follicles and T cell regions. These results
indicated that the newly induced hematopoietic structure was
not a lymphoid organ.
We observed the newly discovered hematopoietic struc-
tures in the omentum with and without fibrous capsule. The
omentum is composed of two mesothelium sheets enclosing a
loose connective tissue that contains some hematopoietic
cells, macrophages, lymphocytes and dendritic cells, called
the Bomental milky spot^ (Platell et al. 2000). Omental milky
spots directly contact with adipocytes, lacking fibrous capsule.
The small size of the structures induced in this study was not
clearly distinct from surrounding tissue, although the larger
structures formed fibrous capsules. In addition, rER-rich fi-
broblasts, actively producing collagen fibers, were observed
in the larger structures. By these results, we believe that the
simple accumulation of hematopoietic cells in the early stage
of the formation process developed into an independent organ
and a fibrous capsule on a larger structure is formed to
Fig. 7 Hematopoietic progenitor cells in the BM and peripheral blood. a
Colony formation (CF) assay in the BM. No significant change was
observed between the controls and animals treated with both NBP and
PHZ (NHP+ PHZ). b Number of lineage-negative, c-kit-positive HPCs
(LK cells) in the BM. The number of these LK cells was significantly
decreased at 1 and 2 days after NBP injection. c CF assay in peripheral
blood. Colony formation was markedly increased in the peripheral blood
of animals treated with both NBP and PHZ compared with the controls. d
The number of LK cells in the peripheral blood. The number of LK cells
was significantly increased at 1 day after NBP injection. e The time-
dependent change of serum G-CSF concentrations. The serum G-CSF
concentration was significantly increased at 1–3 days after NBP injection
compared with 0 days after NBP injection. NS no statistical significance.
*P < 0.05 (vs. control or 0 day)
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maintain the structure such as lymph nodes ontogeny (Bailey
and Weiss 1975).
New Zealand Black mice display an age-associated pro-
gression to chronic lymphocytic leukemia and have well-
developed omental milky spots and a dysfunctional spleen,
which are involved in extramedullary hematopoiesis
(Takemori et al. 1995; Takemori 2007). There is another re-
port that the consecutive injection of a high dose of EPO
induces erythropoiesis in the omental milky spots in the ddY
strain (Hirai et al. 1994). The omental milky spot contains
many macrophage precursors and forms a microenvironment
that promotes differentiation into macrophages (Zhu et al.
1997). The fetal mouse omentum has been shown to be a
source of precursors that exclusively reconstitute Ly1+ B cells
(Kantor et al. 1992). The transposition of the omental pedicle
to injured organs has been used to promote healing and the
omental transposition experiment reported the expansion of
the mass of milky spots and increased VEGF expression
(Litbarg et al. 2007). The peritoneum, including the omentum,
is known to provide a hypoxic microenvironment that is a
suitable niche for cancer stem cells and is associated with
peritoneal metastasis (Miao et al. 2014). Moreover, the
HSCs are localized to the hypoxic region of the BM
(Nombela-Arrieta et al. 2013; Morikawa and Takubo 2015;
Kocabas et al. 2015). These reports support that the microen-
vironment of the omentum is similar to the niche for hemato-
poiesis. We also detected some cytokines that are related to
hematopoiesis, including SCF and SDF-1, in the omentum,
even in normal conditions. In particular, SDF-1 plays an es-
sential role in the homing of HSCs and HPCs and is associated
with extramedullary hematopoiesis (Inra et al. 2015; Mendt
and Cardier 2015). The features of the omentum identified in
this study indicated that it is a suitable microenvironment for
hematopoiesis because the omentum is more likely to be as-
sociated with the formation of the newly discovered structure.
Interestingly, we only observed the hematopoietic structure in
the omentum, not in the mesenterium; these peritoneal tissues
have different origins: the dorsal mesogastrium and dorsal
mesenterium, respectively (Robinson 1899). The cytokines
identified in the omentum were not detected in the mesenteric
lymph nodes. Therefore, the microenvironments in these two
peritoneal tissues might be different.
G-CSF is a cytokine related to granulopoiesis and G-SCF
production is enhanced in inflammation and stimulates
granulopoiesis. G-CSF has other functions, namely to sup-
press osteoblasts lineage cells and inhibit the expression of
some factors, SDF-1, SCF and VCAM-1, which results in
the mobilization of HSCs and HPCs from the BM to periph-
eral tissues (Semerad et al. 2005; Greenbaum and Link 2011).
In this study, we detected an increase in both the serumG-SCF
levels and the numbers of lineage-negative and c-kit-positive
HPCs in the peripheral blood following NBP treatment. The
relationship between bisphosphonates and G-CSF production
is unclear but NBP injection induces some side effects, includ-
ing granulopoiesis, inflammation, extramedullary hematopoi-
esis and necrosis (Nakamura et al. 1999; Yamaguchi et al.
2010) and mediates the significant release of IL-6, TNF-α
and IL-1β (Endo et al. 1992). Moreover, fat-associated lym-
phoid clusters such as omental milky spots are induced by
inflammation (Benezech et al. 2015). These results suggest
that NBP injection induces G-CSF production and that G-
CSF should play an essential role in the formation of the
newly discovered hematopoietic structure.
Taken together, these results suggest that the increased
G-CSF production following the NBP injection mediated
HSCs and/or HPCs mobilization, which colonized the
omentum and provided the niche for hematopoiesis by
expressing some hematopoiesis-related factors, including
SDF-1. Moreover, the high EPO level stimulated erythro-
poiesis, resulting in the formation of the new hematopoi-
etic structures. Our study reveals a previously unknown
mechanism of NBP, the function of the omentum and the
relationship between the peritoneal adipose tissue and he-
matopoietic cells.
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